Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-009311
Filing Date
2018-07-17
Accepted
2018-07-17 17:04:31
Documents
1
Period of Report
2018-07-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3940
  Complete submission text file 0001213900-18-009311.txt   5340
Mailing Address 125 ELM STREET NEW CANAAN CT 06840
Business Address
Steinhart Richard I (Reporting) CIK: 0001293789 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 18957024

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations